"CytoDyn’s Stock, Cash Investor Settlement Gets Final Court Nod
Nov. 3, 2026, 10:20 AM CST
Gillian R. Brassil
Legal Reporter
CytoDyn Inc.’s investor agreement to shell out 49 million shares and $500,000 in cash earned final court approval, ending allegations that it misrepresented progress on regulatory approvals for a therapy to treat HIV and Covid-19.
The settlement class includes those who acquired CytoDyn stock from March 27, 2020, to March 30, 2022, Judge Benjamin H. Settle said Monday. Investors’ counsel will get 25% of the settlement shares in attorneys’ fees and almost $233,000 worth for litigation expenses, the US District Court for the Western District of Washington judge said.
Settle let securities fraud, insider trading, and fraudulent scheme ..."
https://news.bloomberglaw.com/securities-law/...-court-nod